Dyne Therapeutics, Inc. (DYN) › Operating Cash FlowDyne Therapeutics, Inc. (DYN) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$11.83M2020: -$46.51M2021: -$119.56M2022: -$153.65M2023: -$188.16M2024: -$292.37M2025: -$403.21M-$403.21M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$403.21M-37.9%2024-$292.37M-55.4%2023-$188.16M-22.5%2022-$153.65M-28.5%2021-$119.56M-157.1%2020-$46.51M-293.0%2019-$11.83M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share